YANKCOM Partnership Buys Shares of 1,034 Danaher Co. (NYSE:DHR)

YANKCOM Partnership bought a new stake in Danaher Co. (NYSE:DHR) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,034 shares of the conglomerate’s stock, valued at approximately $237,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. FMR LLC increased its position in Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after buying an additional 535,254 shares in the last quarter. International Assets Investment Management LLC increased its position in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after buying an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. grew its position in shares of Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new stake in shares of Danaher during the fourth quarter worth about $74,551,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

NYSE:DHR opened at $209.95 on Friday. The firm has a market capitalization of $151.64 billion, a price-to-earnings ratio of 39.76, a PEG ratio of 2.80 and a beta of 0.83. Danaher Co. has a 1 year low of $209.10 and a 1 year high of $281.70. The business has a 50 day simple moving average of $233.96 and a 200-day simple moving average of $252.39. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 earnings per share. Equities analysts forecast that Danaher Co. will post 7.77 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on DHR. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday. Wells Fargo & Company cut their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Guggenheim began coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price for the company. Scotiabank began coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Finally, TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.